SACITUZUMAB

Clinical trials for SACITUZUMAB explained in plain language.

Never miss a new study

Get alerted when new SACITUZUMAB trials appear

Sign up with your email to follow new studies for SACITUZUMAB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New hope for rare, aggressive kidney cancer after other treatments fail

Disease control Not yet recruiting

This study is testing whether a new drug called sacituzumab tirumotecan can help control an advanced and aggressive form of kidney cancer called SMARCB1-deficient renal medullary carcinoma. It is for adult patients whose cancer has continued to grow despite receiving at least one…

Matched conditions: SACITUZUMAB

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Mar 27, 2026 12:38 UTC

SACITUZUMAB

Get alerted when new SACITUZUMAB trials appear

New hope for rare, aggressive kidney cancer after other treatments fail